← Eichor
Study identifier: NCT06890650 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly Diagnosed Active Crohn Disease

Condition: Crohn Disease  ·  Sponsor: All India Institute of Medical Sciences

PhaseNA
Planned participants168
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

Dysbiosis can be rectified by several methods: antibiotics, prebiotics, probiotics, dietary modulation, and fecal microbiota transplantation. There has been limited success with the isolated use of antibiotics and pre/probiotics in the treatment of IBD. Among the measures of dietary manipulation, the use of exclusive enteral nutrition (EEN) has shown superior, or at least equivalent, efficacy compared with steroids in pediatric CD. Although the results in adults are not as encouraging, recent cohort studies in patients with complicated CD have shown good success rates. Definite exclusion diets that exclude pro-inflammatory dietary constituents have also been tested with good clinical efficacy in patients with CD, who even failed treatment with anti-TNF agents. Various dietary approaches, inclusive of exclusive enteral nutrition, partial enteral nutrition, and Crohn's disease exclusion diet have been reported to be of benefit and are associated with changes in gut microbiome. Fecal microbiota transplantation (FMT) defined as the infusion of fecal suspension from a healthy individual into the gastrointestinal tract of an individual with GI disease carries a diverse population of microbiota and their metabolites and has been tested with varying efficacy in IBD. In general, FMT has shown good success rates in randomized control trials in patients with UC who failed conventional agents. Although limited small RCTs exist in CD, cohort studies have also shown good success rates. The…

This description comes directly from the study's public registry record.

Talk to the study team

Prof Vineet Ahuja, DM Gastroenterology  ·  +91-9810707170  ·  vineet.aiims@gmail.com

Dr Himanshu Narang, DM Gasteroentrology  ·  +91-8800316504  ·  h92narang@gmail.com

Always discuss trial participation with your own doctor first.

Locations (6)

Department of Gastroenterology, Lisie HospitalKochi, Kerala, IndiaNot Yet Recruiting
Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College, SionMumbai, Maharashtra, IndiaNot Yet Recruiting
Department of Gastroenterology and Human Nutrition, All India Institute of Medical SciencesNew Delhi, National Capital Territory of Delhi, IndiaRecruiting
Department of Gastroenterology, Dayanand Medical CollegeLudhiana, Punjab, IndiaNot Yet Recruiting
Department of Gastroentrology, Postgraduate Institute of Medical Education and ResearchChandigarh, Punjab/Haryana, IndiaNot Yet Recruiting
Department of Gastroenterology, Institute of Medical Sciences, Banaras Hindu UniversityVaranasi, Uttar Pradesh, IndiaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06890650